DR. BETH ANN HELLERSTEDT M.D. NPI 1215975487

NPI Details

DR. Beth Ann Hellerstedt, M.D. is a hematology and oncology internal medicine in Round Rock, TX with 29 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Beth Ann Hellerstedt, M.D. NPI is 1215975487. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE
Graduation Year:1997

The provider's business location address is:

2410 ROUND ROCK AVE STE 150
ROUND ROCK, TX
ZIP 78681-019
Phone: (512) 341-8724
Fax: (512) 687-0295

The NPI 1215975487 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Magnesium level (HCPCS:83735)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Reticulated (young) platelet measurement (HCPCS:85055)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Immunologic analysis technique on serum (HCPCS:86320)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Protein measurement, serum (HCPCS:84165)
• Unclassified drugs (HCPCS:J3490)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Ct scan of chest with contrast (HCPCS:71260)
• Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session (HCPCS:G6015)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Phosphate level (HCPCS:84100)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Testosterone (hormone) level, total (HCPCS:84403)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Ringers lactate infusion, up to 1000 cc (HCPCS:J7120)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Ct scan of chest without contrast (HCPCS:71250)
• Uric acid level, blood (HCPCS:84550)
• Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev (HCPCS:G6013)
• Injection of drug or substance into vein (HCPCS:96374)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Vitamin d-3 level (HCPCS:82306)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Automated urinalysis test (HCPCS:81003)
• Heart muscle strain imaging (HCPCS:93356)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Red blood count, automated test (HCPCS:85045)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Declotting of central venous tube (HCPCS:36593)

The enumeration date for this NPI number is 6/2/2006 and was last updated on 12/10/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.